Dialysis industry news

Stories from the dialysis comunity across the globe.



High caffeine levels protective against Alzheimer disease. PDF Print
EurekAlert: "These intriguing results suggest that older adults with mild memory impairment who drink moderate levels of coffee -- about 3 cups a day -- will not convert to Alzheimer's disease -- or at least will experience a substantial delay before converting to Alzheimer's," said study lead author Dr. Chuanhai Cao, a neuroscientist at the USF College of Pharmacy (http://health.usf.edu/nocms/pharmacy/) and the USF Health Byrd Alzheimer's Institute (http://health.usf.edu/nocms/byrd/). "The results from this study, along with our earlier studies in Alzheimer's mice, are very consistent in indicating that moderate daily caffeine/coffee intake throughout adulthood should appreciably protect against Alzheimer's disease later in life."

...

 
New myeloma treatment regimen shows good results. PDF Print
EurekAlert: The researchers, led by Andrzej J. Jakubowiak, M.D., Ph.D., professor of medicine and director of the multiple myeloma program at the University of Chicago Medical Center, found that combining carfilzomib, a next generation proteasome inhibitor, with two standard drugs – lenalidomide and low-dose dexamethasone compared favorably to other frontline regimens.

...

 
Carriage of resistant Staph. may be a family affair. PDF Print
EurekAlert: Of the patients, 61 percent were colonized with MRSA; 30 percent were colonized with methicillin-sensitive S aureus (MSSA), which responds to antibiotics; and 9 percent were colonized with both MRSA and MSSA. The most common site of colonization was the groin region. Of 609 household contacts, 53 percent were colonized with S aureus; 19 percent with MRSA; 32 percent with MSSA; and 2 percent with both MRSA and MSSA, the researchers found.

...

 
Why exercise has a beneficial effect on neuropathic pain. PDF Print
EurekAlert: Exercise also led to reduced expression of inflammation-promoting cytokines in sciatic nerve tissue—specifically, tumor necrosis factor-alpha and interleukin-1-beta. That was consistent with previous studies suggesting that inflammation and pro-inflammatory cytokines play a role in the development of neuropathic pain in response to nerve injury. Exercise also led to increased expression of a protein, called heat shock protein-27, which may have contributed to the reductions in cytokine expression.

...

 
Research and Markets: Finland Nephrology and Urology Devices Investment ... - Business Wire (press release) PDF Print

DUBLIN--(BUSINESS WIRE)--Dublin - Research and Markets (http://www.researchandmarkets.com/research/6pl44c/finland_nephrology) has announced the addition of Global Markets Direct's new report "Finland Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018" to their offering.

“Finland Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018”

Finland Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018, a new report by Global Markets Direct, provides key market data on the Finland Nephrology and Urology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within three market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

Scope

- Market size and company share data for Nephrology and Urology Devices market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within three market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the three market categories.

- Global corporate-level profiles of key companies operating within the Finland Nephrology and Urology Devicesmarket.

- Key players covered include Fresenius Medical Care AG & Co. KGaA, Svenska Cellulosa Aktiebolaget SCA, Gambro AB, Baxter International Inc., ONTEX International N.V., Coloplast A/S and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the Finland Nephrology and Urology Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

For more information visit http://www.researchandmarkets.com/research/6pl44c/finland_nephrology

Source: Global Markets Direct

...

 
<< Start < Prev 581 582 583 584 585 586 587 588 589 590 Next > End >>

Page 587 of 4210
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.